Gum disease treatment: can a hyaluronic acid gel regrow bone as well as the standard?

NCT ID NCT07339605

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a hyaluronic acid gel can help regrow bone lost to severe gum disease, compared to the standard enamel matrix derivative gel or no gel at all. All treatments use a minimally invasive, non-surgical technique. Sixty adults with advanced periodontitis will be followed for one year to measure bone fill and patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hyaluronic acid gel and enamel matrix derivative
What this could lead to
If successful, this could offer a simpler, less invasive option for regenerating bone lost to gum disease, potentially reducing the need for surgery.
What could go wrong
This is a small, early-stage trial with only 60 participants. The results may not apply to everyone, and the benefits over standard care are still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALVEOLAR BONE LOSS* / THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clínica Odontológica de la Universidad de Valencia

    RECRUITING

    Valencia, Valencia, 46010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.